Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 460

Results For "AI"

8367 News Found

Venus Remedies recognized for R&D excellence by DSIR
News | May 19, 2023

Venus Remedies recognized for R&D excellence by DSIR

Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions


KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
News | May 19, 2023

KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr

The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023


Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
News | May 19, 2023

Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr

Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023


Philips’ image-guided navigation increases safety during coronary interventions
News | May 17, 2023

Philips’ image-guided navigation increases safety during coronary interventions

Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%


Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr
News | May 17, 2023

Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr

The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023


Envision Scientific receives IGBC Gold Certification for India factory
News | May 17, 2023

Envision Scientific receives IGBC Gold Certification for India factory

Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure


Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose
News | May 17, 2023

Emcure Pharmaceuticals to launch the750 mg injectable variant of ferric carboxymaltose

Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes


Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData
News | May 17, 2023

Farxiga’s expanded approval highlights potential to differentiate in HF space, says GlobalData

Farxiga is expected to have such a strong influence on the market due to the impressive results


Hikal announces USFDA audit with zero observations
Drug Approval | May 16, 2023

Hikal announces USFDA audit with zero observations

This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites


Mandaviya addresses the G7 Ministerial Meeting on global health architecture
Policy | May 16, 2023

Mandaviya addresses the G7 Ministerial Meeting on global health architecture

Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security